ArticleMolecular endocrinology (Baltimore, Md.)2012

In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancer.

Howard C Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.